BRITTNEY BOWEN: Open Payments
NPI 1801337753 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 60 payments from 16 companies in 2025. Trend: 2023 $500 · 2024 $833 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $281 |
| GlaxoSmithKline, LLC. | 19 | $140 |
| Phathom Pharmaceuticals, Inc. | 10 | $83 |
| Abbott Laboratories | 1 | $62 |
| Edwards Lifesciences Corporation | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Boston Scientific Corporation | 1 | $39 |
| Novo Nordisk Inc | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $25 |
Products named: UBRELVY, TRELEGY ELLIPTA, QULIPTA, VOQUEZNA, AMPLATZER AMULET, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), XIFAXAN, WATCHMAN FLX.
Industry payments across ID — which companies pay providers there.
